What is the current Price Target for the Cogent Biosciences Inc stock?

The average Cogent Biosciences Inc target price is $16.55. This is 210.42% higher than the current stock price. The highest price target is 350.28%, the lowest is 50.09%. 11 Analysts have issued a price target Cogent Biosciences Inc 2026 .

How high will the Cogent Biosciences Inc stock rise?

No reliable answer can be given as to how high the Cogent Biosciences Inc stock will rise. The performance of stocks, including the Cogent Biosciences Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cogent Biosciences Inc stock today?

The performance of Cogent Biosciences Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cogent Biosciences Inc stock fall?

The decline in Cogent Biosciences Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cogent Biosciences Inc Forecast, price target & analysts

$4.75

10.88% today

Nasdaq, Apr 04, 07:48 pm CET

ISIN

US19240Q2012

Symbol

COGT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Cogent Biosciences Inc Target price 2025 - Analyst rating & recommendation

Cogent Biosciences Inc Classifications & Recommendation:

Buy

75%

Hold

25%

Cogent Biosciences Inc Price Target

Target Price	$16.55
Price	$5.33
Potential	210.42% register free of charge
Number of Estimates	11

	11 Analysts have issued a price target Cogent Biosciences Inc 2026 . The average Cogent Biosciences Inc target price is $16.55. This is 210.42% register free of charge higher than the current stock price. The highest price target is $24.00 350.28% register free of charge , the lowest is $8.00 50.09% register free of charge .
	A rating was issued by 12 analysts: 9 Analysts recommend Cogent Biosciences Inc to buy, 3 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cogent Biosciences Inc stock has an average upside potential 2026 of 210.42% register free of charge . Most analysts recommend the Cogent Biosciences Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.46	-2.28
	1.65%	7.32%
P/E		negative

5 Analysts have issued a Cogent Biosciences Inc forecast for earnings per share. The average Cogent Biosciences Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.46	1.65%
2025	$-2.28 7.32% Unlock
2026	$-1.95 14.47% Unlock
2027	$-1.00 48.72% Unlock
2028	$0.82 182.00% Unlock
2029	$1.75 113.41% Unlock

Current	-2.16	22.58%
2025	-2.34 8.33% Unlock
2026	-2.73 16.67% Unlock
2027	-5.31 94.51% Unlock
2028	6.50 222.41% Unlock
2029	3.05 53.08% Unlock

Cogent Biosciences Inc...

Current Cogent Biosciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Scotiabank	Locked ➜ Locked	Locked	Mar 07 2025
Baird	Locked ➜ Locked	Locked	Feb 27 2025
Needham	Locked ➜ Locked	Locked	Feb 26 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 14 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 11 2024
Needham	Locked ➜ Locked	Locked	Dec 11 2024
Needham	Locked ➜ Locked	Locked	Dec 10 2024

Analyst Rating	Date
Locked Scotiabank: Locked ➜ Locked	Mar 07 2025
Locked Baird: Locked ➜ Locked	Feb 27 2025
Locked Needham: Locked ➜ Locked	Feb 26 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 14 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 11 2024
Locked Needham: Locked ➜ Locked	Dec 11 2024
Locked Needham: Locked ➜ Locked	Dec 10 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now